Construction of disability risk prediction model for the elderly based on machine learning.

Sci Rep

School of Nursing, Zhejiang Chinese Medical University, 548 Binwen Road, Binjiang District, Hangzhou, 310053, Zhejiang Province, People's Republic of China.

Published: May 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The study aimed to develop a predictive model using machine learning algorithms, providing healthcare professionals with a novel tool for assessing disability risk in older adults. Data from the 2018 and 2020 waves of the China Health and Retirement Longitudinal Study were utilized, including 3,172 participants aged 65 years and older with no baseline disability. In this study, five machine learning algorithms were employed to construct risk assessment and prediction models for disability in older adults. The Shapley Additive Explanations method was applied to analyze the independent predictors of disability risk. In total, 695 participants (21.9%) were disabled during follow-up. Among the five machine learning models, prediction models constructed using random forest and extreme gradient boosting methods showed superior performance, achieving F1 scores of 0.92 and 0.86 and accuracies of 0.92 and 0.85, respectively. Key predictors of disability risk included self-rated health, education, sleep duration, alcohol consumption, depressive symptoms, hypertension, and arthritis. The Machine learning models for assessing and predicting disability risk in older adults, particularly those developed using RF and XGBoost algorithms, exhibited strong predictive capabilities. These findings highlight the potential of these models for practical application in clinical and public health settings, warranting further exploration and validation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12064728PMC
http://dx.doi.org/10.1038/s41598-025-01404-5DOI Listing

Publication Analysis

Top Keywords

disability risk
20
machine learning
20
older adults
12
learning algorithms
8
risk older
8
prediction models
8
predictors disability
8
learning models
8
risk
6
disability
6

Similar Publications

Purpose: To examine associations between special education, chronic health conditions (CHCs), and college graduation in survivors of childhood cancer and their siblings.

Methods: Childhood Cancer Survivor Study participants included 23,082 5-year survivors (53.7% male; median [IQR] age at diagnosis, 6 [3-13] years; age at evaluation, 31.

View Article and Find Full Text PDF

Background: Filarial lymphedema, caused by lymphatic filariasis, is characterized by chronic swelling and recurrent skin infections. Acute adenolymphangitis (ADL) episodes significantly exacerbate morbidity. Diabetes mellitus (DM) increases susceptibility to infections; however, the relationship between diabetes and ADL frequency and severity in filarial lymphedema patients remains unclear.

View Article and Find Full Text PDF

Background: Stroke persists as the second leading global cause of mortality and disability. We analyzed G20 nations using Global Burden of Disease (GBD) 2021 data (1990-2021) to provide a new perspective.

Methods: We obtained age-standardized rates (ASR) of stroke mortality, incidence, prevalence, and YLLs (years of life lost) across G20 nations.

View Article and Find Full Text PDF

ObjectiveTo determine the effectiveness of bilateral decompression combined with a unilateral transforaminal lumbar interbody fusion approach in centralizing a lordotic cage and preventing contralateral radiculopathy by ensuring equal foraminal elevation.MethodsThis is a retrospective cohort study based on clinical records and radiological data. Eighty-seven patients diagnosed with lumbar spinal stenosis at L3-S1 levels underwent bilateral decompression and transforaminal lumbar interbody fusion between 2017 and 2022.

View Article and Find Full Text PDF

Brexpiprazole is a second-generation antipsychotic with multiple indications, including the treatment of schizophrenia. As a partial dopamine agonist, brexpiprazole differs from most other antipsychotics, yet uncertainties about its full mechanism of action have led to some ambiguity among prescribers. To address this gap, an international panel of psychiatric experts was organized and convened with funding from Otsuka Pharmaceutical Europe Ltd and H.

View Article and Find Full Text PDF